Video

Aleksandra Rachitskaya from Cole Eye Institute: ARGUS II Provides Hope of New Vision for Patients

Author(s):

For patients with retinitis pigmentosa the loss of vision can be a difficult consequence of the condition. An implanted device may not give them back the sight they once had but it can provide a chance to see the world around them in a new way.

For patients with retinitis pigmentosa the loss of vision can be a difficult consequence of the condition. An implanted device may not give them back the sight they once had but it can provide a chance to see the world around them in a new way.

As this is an extremely rare condition Aleksandra Rachitskaya, MD, from the Cole Eye Institute said only a very limited patient population can benefit from the system at this time. While it could be used for other conditions in the future the Cleveland based doctor said her institution is among the leaders in the field having performed the procedure 6 times. Rachitskaya discussed the procedure while attending the annual meeting of the American Society of Retina Specialists in San Francisco.

Related Videos
Greg A. Sachs, MD I Credit: Regenstrief Institute
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.